Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-21

Clinical Trial Update: Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating acipimox effects on insulin action, vascular function, and muscle function in individuals with type 1 diabetes; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acipimox (Acipimox)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2022-01-21